Shuiping Gao
- Cancer Research top 10%
-
- HER2/EGFR in Cancer Research 6
- Cancer Treatment and Pharmacology 3
-
- Monoclonal and Polyclonal Antibodies Research 5
- Radiopharmaceutical Chemistry and Applications 2
-
- Advanced Breast Cancer Therapies 2
-
- Galectins and Cancer Biology 3
-
- Cancer Research and Treatments 2
-
- BRCA gene mutations in cancer 2
- Co-authors
- Hefen SunLiangdong LiWei JinYang ZhaoWenyan FuHonglin JiangLipeng YangXin Hu
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Shuiping Gao
26 papers receiving 531 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 194
- Oncology 229
- Molecular Biology 263
- Radiology, Nuclear Medicine and Imaging 74
- Pulmonary and Respiratory Medicine 99
Countries citing papers authored by Shuiping Gao
This map shows the geographic impact of Shuiping Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuiping Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuiping Gao more than expected).
Fields of papers citing papers by Shuiping Gao
This network shows the impact of papers produced by Shuiping Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuiping Gao. The network helps show where Shuiping Gao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuiping Gao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 36 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 2 | |
| 11 | 2021 | 20 | |
| 12 | 2021 | 9 | |
| 13 | 2018 | 19 | |
| 14 | 2017 | 133 | |
| 15 | 2017 | 13 | |
| 16 | 2015 | 20 | |
| 17 | 2015 | 58 | |
| 18 | 2015 | 32 | |
| 19 | 2013 | 25 | |
| 20 | 2010 | 1 |
About Shuiping Gao
Shuiping Gao is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 28 papers that have together received 539 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer Treatment and Pharmacology (3 papers), Galectins and Cancer Biology (3 papers), Advanced Breast Cancer Therapies (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Cancer Research and Treatments (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Cancer Research (194 citations), Oncology (229 citations) and Molecular Biology (263 citations). Shuiping Gao has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Hefen Sun, Liangdong Li, Wei Jin, Yang Zhao, Wenyan Fu, Honglin Jiang, Lipeng Yang, Xin Hu, Min‐Te Chen and Honglin Jiang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.